论文部分内容阅读
目的 :讨论并分析在慢阻肺的临床治疗中丹参注射液与参附注射液的临床效果。方法 :选取我院2011年10月~2014年9月期间收治的60例慢阻肺患者为研究对象,征得患者本人及家属同意的情况下随机将60例患者分为观察组(n=30)和对照组(n=30),对照组行西医常规治疗,观察组在西医治疗的基础上加入丹参注射液和参附注射液进行治疗,比较两组患者的治疗效果及不良反应情况。结果:两组患者治疗效果比较,观察组患者显著优于对照组,差异有明显统计学意义(P<0.05)。结论:在慢阻肺患者的临床治疗中,采用丹参注射液与参附注射液进行治疗,整体效果较好,方法值得在临床实践中予以借鉴。
Objective: To discuss and analyze the clinical effect of Danshen injection and Shenfu injection in the clinical treatment of chronic obstructive pulmonary disease. Methods: Sixty COPD patients admitted from October 2011 to September 2014 in our hospital were enrolled in this study. Sixty patients were randomly divided into observation group (n = 30) with consent of patients and their relatives ) And control group (n = 30). The control group received conventional treatment of Western medicine. The observation group was treated with Danshen injection and Shenfu injection on the basis of western medicine treatment. The therapeutic effect and adverse reactions of the two groups were compared. Results: Compared with the control group, the difference between the two groups was statistically significant (P <0.05). Conclusion: In the clinical treatment of patients with COPD, Salviae Miltiorrhizae injection and Shenfu Injection are used for treatment, and the overall effect is good. The method is worthy of reference in clinical practice.